{
  "slug": "schr-dinger",
  "name": "schr-dinger",
  "description": "Schrödinger is a leading provider of physics-based computational platform solutions that enable discovery of novel molecules for drug development and materials science. Their software accelerates the discovery and optimization of small molecules and biologics.",
  "url": "https://optimly.ai/brand/schr-dinger",
  "websiteUrl": "https://schr-dinger.com/",
  "logoUrl": "https://logo.clearbit.com/schr-dinger.com",
  "baiScore": 54,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Scientific Software",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:03:02.391Z",
  "verifiedVitals": {
    "website": "https://schr-dinger.com",
    "founded": "1990",
    "headquarters": "New York, NY",
    "pricing_model": "Subscription-based licensing (annual/multi-year), enterprise agreements, cloud-based access.",
    "core_products": "Maestro (integrated suite), Glide, Desmond, FEP+, LiveDesign, Biologics solution, Materials Science platform.",
    "key_differentiator": "A unique, highly accurate physics-based computational platform integrated with machine learning, offering a comprehensive and predictive suite for the entire molecular discovery and design workflow, backed by strong scientific expertise.",
    "target_markets": "Pharmaceutical, biotechnology, academic research, materials science, chemicals, agrochemicals.",
    "employee_count": "1,000+",
    "funding_stage": "Publicly traded (NASDAQ: SDGR)",
    "subcategory": "Drug Discovery & Materials Science Software"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional Wet-Lab Experimentation: Reliance on physical synthesis, screening, and testing of molecules in a laboratory setting, which is often time-consuming, resource-intensive, and less predictabl",
      "Contract Research Organizations (CROs): Outsourcing computational chemistry and drug discovery tasks to specialized third-party service providers, which can be costly and may lead to less direct contr",
      "Continue with Existing Methods: Maintaining current R&D processes without adopting advanced computational platforms, potentially leading to slower discovery timelines, higher costs, and reduced compet"
    ],
    "solutionIntents": [
      "Schrödinger drug discovery software",
      "computational chemistry platform",
      "materials science simulation tools",
      "Open-Source Molecular Modeling Tools: Utilizing free or academic molecular modeling software (e.g., PyMOL, GROMACS, LAMMPS) which may lack the integrated workflows, user support, and comprehensive fea"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786565662209
}